...
首页> 外文期刊>Journal of Molecular Liquids >Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine
【24h】

Immunoinformatics characterization of SARS-CoV-2 spike glycoprotein for prioritization of epitope based multivalent peptide vaccine

机译:SARS-COV-2穗糖蛋白的免疫信息特征在于基于表位的多价肽疫苗的优先级

获取原文
获取原文并翻译 | 示例

摘要

The COVID-19 pandemic caused by SARS-CoV-2 is a public health emergency of international concern and thus calling for the development of effective and safe therapeutics and prophylactics particularly a vaccine to protect against the infection. SARS-CoV-2 spike glycoprotein is an attractive candidate for a vaccine, antibodies, and inhibitors development because of the many roles it plays in attachment, fusion and entry into the host cell. In the present investigation, we characterized the SARS-CoV-2 spike glycoprotein by immunoinformatics techniques to put forward potential B and T cell epitopes, followed by the use of epitopes in construction of a multi-epitope peptide vaccine construct (MEPVC). The MEPVC revealed robust host immune system simulation with high production of immunoglobulins, cytokines and interleukins. Stable conformation of the MEPVC with a representative innate immune TLR3 receptor was observed involving strong hydrophobic and hydrophilic chemical interactions, along with enhanced contribution from salt-bridges towards inter-molecular stability. Molecular dynamics simulation in aqueous milieu aided further in interpreting strong affinity of the MEPVC for TLR3. This stability is the attribute of several vital residues from both TLR3 and MEPVC as shown by radial distribution function (RDF) and a novel axial frequency distribution (AFD) analytical tool. Comprehensive binding free energies estimation was provided at the end that concluded major domination by electrostatic and minor from van der Waals. Summing all, the designed MEPVC has tremendous potential of providing protective immunity against COVID-19 and thus could be considered in experimental studies. (C) 2020 Elsevier B.V. All rights reserved.
机译:SARS-COV-2引起的Covid-19大流行是国际问题的公共卫生应急,从而呼吁开发有效和安全的治疗方法和预防性,特别是疫苗以防止感染。 SARS-COV-2穗糖蛋白是疫苗,抗体和抑制剂发育的有吸引力的候选者,因为它在附着,融合和进入宿主细胞中起作用的许多角色。在本发明的研究中,我们通过免疫信息技术表征了SARS-COV-2穗糖蛋白,以提出潜在的B和T细胞表位,然后使用表位在构建多表位肽疫苗构建体(MEPVC)中。 MEPVC揭示了具有高生产免疫球蛋白,细胞因子和白细胞介素的强大宿主免疫系统模拟。观察到涉及强疏水性和亲水化学相互作用的代表性先天免疫TLR3受体的MEPVC的稳定构象,以及来自盐桥朝着分子间稳定性的增强贡献。在解释MEPVC对TLR3的强辅助性的进一步辅助分子动力学模拟。这种稳定性是来自TLR3和MEPVC的几个重要残留的属性,如径向分布函数(RDF)和新型轴向频率分布(AFD)分析工具所示。最后提供了综合束缚能量估计,最后通过van der waals静电和未成年人结束了主要统治。总而言之,设计的MEPVC对Covid-19提供保护性免疫力的巨大潜力,因此可以在实验研究中考虑。 (c)2020 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号